Paul Y. Song, MD

Paul Y. Song, MD has a diverse work experience in the medical and biotech industries. Paul Y. is currently the Chief Executive Officer and Vice Chairman of the Board at NKGen Biotech, Inc. and a Co-Founder & Senior Advisor at Fuse Biotherapeutics. Additionally, they serve as a Board Member at pepromene bio and as the Chief Medical Advisor at Hawkeye Bio, Inc. In the past, they have held positions such as Partner at Calyx Peak, Senior Medical Advisor at Supportive Therapeutics, and Chief Medical Officer at Cynvenio Biosystems, Inc. Dr. Song has also worked as a Staff Physician at Western Tumor Medical Group and as an Attending Staff Physician at Cedars-Sinai Medical Center. Throughout their career, they have been involved in various leadership roles, clinical trials, and interactions with international KOLs.

Dr. Paul Y. Song completed their education history as follows:

From 1995 to 1996, they served as an ASTRO Research Fellow in the Department of Radiation and Cellular Oncology at The University of Chicago Pritzker School of Medicine.

In 1995, they were a Visiting Fellow at Institut Gustave Roussy, where they specialized in Brachytherapy.

From 1992 to 1995, Dr. Song pursued their Chief Resident position in Radiation and Cellular Oncology at The University of Chicago Pritzker School of Medicine.

In 1987, they earned their MD from The George Washington University School of Medicine and Health Sciences.

In 1983, they obtained a BA with honors in Biological Sciences from the University of Chicago.

Prior to their higher education, they completed their high school studies at Millburn High School from 1980 to 1983.

Dr. Paul Y. Song holds an additional certification from the American Board of Radiology, but no further details regarding the institution or specific year of attainment are available.